Trek Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-414
Closed -$215K 426
2024
Q3
$215K Buy
414
+1
+0.2% +$534 0.02% 365
2024
Q2
$224K Sell
413
-21
-5% -$11.1K 0.02% 358
2024
Q1
$225K Sell
434
-260
-37% -$129K 0.02% 359
2023
Q4
$327K Buy
+694
New +$321K 0.03% 230
2023
Q3
Sell
-465
Closed -$207K 293
2023
Q2
$207K Sell
465
-14
-3% -$6.46K 0.02% 257
2023
Q1
$220K Sell
479
-27
-5% -$12.8K 0.02% 228
2022
Q4
$260K Sell
506
-136
-21% -$69.1K 0.03% 205
2022
Q3
$292K Sell
642
-67
-9% -$32.1K 0.03% 172
2022
Q2
$342K Sell
709
-439
-38% -$217K 0.03% 164
2022
Q1
$564K Buy
1,148
+91
+9% +$41.6K 0.05% 130
2021
Q4
$490K Sell
1,057
-269
-20% -$113K 0.05% 125
2021
Q3
$494K Buy
1,326
+380
+40% +$144K 0.05% 112
2021
Q2
$361K Buy
946
+228
+32% +$87.1K 0.04% 138
2021
Q1
$258K Buy
+718
New +$231K 0.03% 156

Other funds holding ELV

Trek Financial's ELV Position: Q4 2024 in Review

Trek Financial sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 414 shares — an estimated $215K sold.

Trek Financial first reported a position in ELV in Q1 2021 and held it in 14 quarters. The position peaked at $564K in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Trek Financial reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Trek Financial sold 414 Elevance Health shares in Q4 2024, an estimated $215K.
  • Trek Financial first reported a position in Elevance Health in Q1 2021 and held it in 14 quarters.
  • Trek Financial's Elevance Health position peaked at $564K in Q1 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Trek Financial's 13F filing for Q4 2024, filed 13 Feb 2025.